These Analysts Revise Their Forecasts On RH Following Q2 Results

Benzinga Earnings
10 hours ago

RH (NYSE:RH) on Thursday reported better-than-expected second-quarter earnings.

RH reported quarterly earnings of $2.70 per share, which beat the Street estimate of $1.78 by 51.69%, per Benzinga Pro data. Quarterly revenue of $922.15 million missed the analyst consensus estimate of $936.25 million, but was up from $899.15 million in the same period last year.

RH narrowed its fiscal 2026 revenue outlook to a range of $3.63 billion to $3.68 billion, versus the $3.63 billion analyst estimate.

RH shares gained 1.5% to trade at $136.00 on Friday.

These analysts made changes to their price targets on RH following earnings announcement.

  • Baird analyst Peter Benedict maintained the stock with a Neutral and lowered the price target from $165 to $160.
  • B of A Securities analyst Christopher Nardone maintained the stock with an Underperform rating and lowered the price target from $156 to $114.
  • UBS analyst Michael Lasser maintained the stock with a Neutral and lowered the price target from $155 to $154.
  • Wells Fargo analyst Zachary Fadem maintained the stock with an Overweight rating and lowered the price target from $225 to $175.
  • TD Cowen analyst Max Rakhlenko maintained the stock with a Buy and lowered the price target from $220 to $190.
  • JP Morgan analyst Christopher Horvers maintained the stock with an Overweight rating and cut the price target from $212 to $190.
  • Telsey Advisory Group analyst Cristina Fernandez maintained the stock with a Market Perform and raised the price target from $140 to $155.
  • BNP Paribas analyst Chris Bottiglieri reiterated the stock with an Underperform rating and cut the price target from $90 to $81.

Considering buying RH stock? Here’s what analysts think:

Photo via Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10